Jumpstart Health Investors

We focus on investment opportunities within the healthcare and life science markets where we can identify value early. At the core of our investment philosophy is a committed and collaborative approach to working with management teams and syndicate partners to build successful companies. We work actively with founders, providing guidance, support and access to our network. We strongly believe that no two investments are the same and support the most suitable business model for each individual venture, working with management teams to formulate strategies to achieve financial independence. We are comfortable financing companies by ourselves and, if appropriate, working closely with the founders to help build a syndicate of co-investors who bring complementary relationships and share our vision. We have a 14-year history of continuous dedication to the fast growing MedTech sector and a history of backing successful entrepreneurs transforming healthcare through MedTech innovation. Investment Strategy Focus: Within the broader healthcare market, we focus our investments on medical technologies including medical devices, diagnostics, drug delivery, and digital health. We back both first-time and experienced founders, who value our participation as well our capital. Stage: We are typically the first institutional investor and support companies through early product and clinical development and often through the regulatory process. We make our first investment at the seed through series B stage, based on when the risk of translation from pre-clinical to clinical is at its lowest. We are life cycle investors and continue to support our portfolio companies through to exit. Capital Efficiency: We invest in companies that are able to demonstrate early and meaningful clinical value with minimum capital invested and preserve the most appropriate exit opportunity. Therapeutic Indications: While we are agnostic to therapeutic indication, we invest in companies developing products that address large, global markets and where there is significant unmet clinical need. We particularly like therapeutic devices that significantly improve patient outcomes and diagnostics that fundamentally change the course of therapeutic intervention.

VentureBlick is a super incubator for medtech. We provide a fully customisable one-stop solution to develop, test, and market healthcare innovations. Leveraging our global advisor network, the deep industry roots of our founding team, and extensive partnership, VentureBlick streamlines the startup journey, from ideation and testing to venture building and market success. ​ Our global VB Advisory Network has more than 1,200 medical and industry advisors, from more than 50 countries covering over 30 specialty areas. They play important roles in different capacities and different stages of startup development, to help accelerate innovations. ​ VentureBlick was founded in 2022 by senior healthcare executive, Chris Lee, with the vision of helping healthcare startups thrive. ​ We are headquartered in Singapore with presences in Australia, China, Germany, India, Korea, and USA.

Canada’s leading digital healthcare Venture Capital firm, offering local depth with global reach. We are healthcare practitioners, operators and founders with over 100 years’ experience and a deep network. We focus on early stage and high-growth companies shaping the future of healthcare delivery and empowering them to scale and grow. How We InvestStage: Investments will be in early stage companies ranging from pre-Seed rounds through pre-IPO with initial investments focused on Seed and Series A rounds Areas: We look for groundbreaking HealthTech ideas focusing on digitization of healthcare, emergence of consumer MedTech, and consumerization of health and wellness Locations: We invest primarily in companies located in Canada, the US and Israel that target markets in North America and Europe

At Boomerang Ventures, we believe better patient care begins with identifying and solving the biggest challenges in healthcare. Boomerang Ventures partners with founders, investors, and institutions that are leveraging new technologies to disrupt healthcare for the better. With our combination studio and venture fund, we provide the collaborative direction, deep industry expertise, and continuum of support founders need to take their innovations from ideation to market. Seamless Approach to Innovation. Our combination studio and fund work together to bring transformative healthcare ideas to life. Connected Health Technology Focus. We build and invest in connected health companies that are shaping a better future for healthcare. Collaborative Investors. We value our partners’ perspectives and work collaboratively to realize our shared vision. CONNECTED HEALTH TECHNOLOGY. Between rising costs, aging populations, staffing shortages, and increasing chronic disease, our healthcare system is struggling to provide the quality of care that patients need and deserve. Our experienced team has been in the Midwest healthcare and life science ecosystem for decades and knows what goes into launching, growing, and scaling successful healthcare companies. With our fund and studio, we are building health tech companies to improve the quality, accessibility, delivery, efficiency, and overall experience of patient care. We make investments in high-potential Midwest companies where our team can drive outsized impact. We focus on key healthcare sectors experiencing accelerated digital and care model transformation, including machine learning, artificial intelligence, virtual care, remote patient management and more. Together, these interconnected areas are paving the way for a brighter future in healthcare. OUR CORE VALUES. Driving the future of healthcare technology from the Midwest, for the world. Intentional Innovation: We push ourselves to think beyond the obvious. We leverage flexible creativity and structured methodology to innovate a future we all deserve. Committed To Collaboration: Our best work happens collaboratively as a team. We listen well and communicate constructively with each other and our partners to create lasting impact. Results that Matter: We focus on positively impacting patient experiences and outcomes. We set high-performance goals and follow through to improve the health of our communities and beyond.

DaVita Venture Group is committed to building partnerships with health care innovators to help improve the lives of patients with kidney disease and related conditions. Together, we believe we can transform the future of patient care for the better. Our Strategy We aim to invest in, acquire, and co-develop products, solutions and businesses that improve care for patients with kidney disease and related conditions. PrioritiesCare Delivery Models: Advancements to expand access to care and improve clinical outcomes through adoption of tech-enabled services, home treatments and value-based care Life Sciences: Pharmaceuticals, medical devices and diagnostics that can improve clinical outcomes and patient experience while reducing costs Digital Health: Products and services that leverage technology, data and connectivity to improve care delivery

Through its activities, Technology Ventures facilitates promising inventions to improve the quality of life for patients around the world. The mission of Technology Ventures is to promote the commercial development of Cedars‑Sinai research into products and services that advance healthcare and improve patient wellbeing. Technology Ventures actively seeks industry partners to develop these technologies and works to establish mutually beneficial long‑term relationships.